US STOCK
TMO Stock Analysis
US stocks · market data · technical indicators
Thermo Fisher Scientific, Inc.
TMOUS stocksQuote delayed 15 min
10/26 下午12:19 updated
$673.82
-2.72-0.40%
Open
$672.69
High
$677.28
Low
$662.50
Volume
204.10萬
TMO price history
-0.70%Open
678.60
Latest
673.82
High
696.49
Low
651.98
Average
672.10
Advertisement
Financial snapshot
TMO - Thermo Fisher Scientific Inc.
EPS
18.96USD
Forward EPS
27.74USD
P/E
35.54x
Forward P/E
24.29x
P/B
4.55x
ROE
13.38%
ROA
5.23%
Operating margin
20.19%
Profit margin
14.94%
Revenue growth
9.10%
Earnings growth
8.70%
Dividend yield
0.28%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $11.99B | $11.01B | $12.21B | $11.12B | $10.85B |
| Gross profit | $4.88B | $4.43B | $5.01B | $4.58B | $4.41B |
| Operating income | $2.19B | $1.91B | $2.30B | $2.08B | $1.92B |
| Net income | $1.74B | $1.65B | $1.96B | $1.62B | $1.62B |
| Basic EPS | 4.68 | 4.44 | 5.22 | 4.28 | 4.28 |
| Diluted EPS | 4.68 | 4.43 | 5.21 | 4.27 | 4.28 |
Estimates vs actuals
Next earnings
2027-01-28
EPS estimate
7.14
Revenue estimate
$12.86B
Last surprise
+4.33%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2027-01-28 | 7.14 | Not reported | — |
| 2026-10-21 | 6.40 | 6.68 | +4.33% |
| 2026-07-23 | 5.71 | 6.03 | +5.55% |
| 2026-04-23 | 5.24 | 5.44 | +3.79% |
| 2026-01-29 | 6.45 | 6.57 | +1.87% |
| 2025-10-22 | 5.50 | 5.79 | +5.32% |
| 2025-07-23 | 5.23 | 5.36 | +2.55% |
| 2025-04-23 | 5.10 | 5.15 | +0.94% |
| 2025-01-30 | 5.94 | 6.10 | +2.66% |
| 2024-10-23 | 5.25 | 5.28 | +0.50% |
| 2024-07-24 | 5.13 | 5.37 | +4.72% |
| 2024-04-24 | 4.71 | 5.11 | +8.45% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| VANGUARD GROUP INC | 2025-12-31 | $19.8B | 0.29% |
| BlackRock Inc. | 2024-06-30 | $16.3B | 0.37% |
| STATE STREET CORP | 2026-06-30 | $8.4B | 0.25% |
| CITADEL ADVISORS LLC | 2026-06-30 | $288.3M | 0.03% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $8.5M | 0.01% |
| Bridgewater Associates, LP | 2026-06-30 | $6.5M | 0.03% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$750.92
Target range
$560.00 – $830.00
Implied upside
11.44%
Strong buy
3
Buy
20
Hold
3
Sell
0
Strong sell
1
Dividends
Annual yield
0.27%
Frequency
Quarterly
Recent payouts
- 2026-09-15$0.4700
- 2026-06-15$0.4700
- 2026-03-13$0.4700
- 2025-12-15$0.4300
Advertisement